Dominican Republic vs Mauritania: Access to anti-retroviral drugs, female
Dominican Republic
68.0%
in 2024
Mauritania
68.0%
in 2024
Dominican Republic rank
86th
Mauritania rank
86th
Access to anti-retroviral drugs, female over time
- Dominican Republic
- Mauritania
How they compare
Dominican Republic currently reports 68.0% against 68.0% in Mauritania, a difference of 0.0%.
The two have swapped places 6 times across 25 shared years of data; in 2000 it was Mauritania ahead.
Dominican Republic ranks 86th and Mauritania ranks 86th of 141 countries.
Mauritania has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Dominican Republic | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.1% | 5.6% | 0.5% | Mauritania |
| 2010s | 35.0% | 35.7% | 0.7% | Mauritania |
| 2020s | 60.4% | 60.4% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Dominican Republic or Mauritania?
- Dominican Republic, at 68.0% against 68.0% in Mauritania as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Dominican Republic and Mauritania?
- 0.0%, with Dominican Republic ahead.
- How many years of comparable data are there for Dominican Republic and Mauritania?
- 25 years are reported by both, from 2000 to 2024.
- How do Dominican Republic and Mauritania rank globally for access to anti-retroviral drugs, female?
- Dominican Republic ranks 86th and Mauritania ranks 86th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.